Drug Trial Radar · NCT00525798
A Study to Evaluate Oral Salmon Calcitonin in the Treatment of Osteoporosis in Postmenopausal Women Taking Calcium and Vitamin D
Last checked: Nov 19, 2026Latest source record: Oct 29, 2012 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
4,665
Actual
Start
Mar 2007
Primary completion
Aug 2011
Study completion Nov 2011
Sponsor
- Lead sponsor
- Nordic Bioscience A/SIndustry
- Sponsor type
- Industry
- Collaborators
- Novartis
- First posted
- Sep 6, 2007
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- Female only, from 55 years, up to 85 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this Phase III study is to evaluate the efficacy and safety of oral salmon calcitonin in the treatment of patients with osteoporosis
Conditions
- Osteoporosis
Interventions
SMC021 Oral calcitoninDrug
0.8mg SMC021 - oral calcitonin, once daily
SMC021 PlaceboDrug
SMC021 - Placebo, once daily
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Patients With New Vertebral FracturesTime frame: From baseline to month 36
Locations
16 sites in 12 countries. Site status is shown where the registry gives one.
United Osteporosis Centers
Gainesville, Georgia
Michigan Bone & Mineral Clinic PC,
Detroit, Michigan
Oregon Osteoporosis Center
Portland, Oregon
CCBR Brazil
Rio de Janeiro, Brazil
CCBR China
Beijing, China
CCBR Czech
Pardubice, Czechia
CCBR Aalborg
Aalborg, Denmark
CCBR Ballerup
Ballerup Municipality, Denmark
CCBR Vejle
Vejle, Denmark
CCBR Estonia
Tallinn, Estonia
Hopital Edouard Herriot
Lyon, France
CCBR Hong Kong
Hong Kong, Hong Kong
Department of Internal Medicine, University of Florence
Florence, Italy
CCBR Lithuania
Vilnius, Lithuania
CCBR Poland
Warsaw, Poland
CCBR Romania
Bucharest, Romania
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.